CRYOPORT, INC. Employee Count
The employee counts CRYOPORT, INC. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 738; Filing 2026-03-05; Lease expense per employee $11,933.60.
- 2024-12-31: Employees (as filed) 1,100; Filing 2025-03-07; Lease expense per employee $5,511.82.
- 2023-12-31: Employees (as filed) 1,170; Filing 2024-03-13; Lease expense per employee $4,546.15.
- 2022-12-31: Employees (as filed) 1,024; Filing 2023-02-28; Lease expense per employee $5,464.84.
- Available history
- 2019-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 738 full-time | 2026-03-05 | $11,933.60 total lease cost |
| 2024-12-31 | 1,100 full-time | 2025-03-07 | $5,511.82 total lease cost |
| 2023-12-31 | 1,170 full-time | 2024-03-13 | $4,546.15 total lease cost |
| 2022-12-31 | 1,024 full-time | 2023-02-28 | $5,464.84 total lease cost |
| 2021-12-31 | 847 full-time | 2022-02-28 | $5,460.45 total lease cost |
| 2020-12-31 | 625 full-time | 2021-03-01 | $3,041.60 total lease cost |
| 2019-12-31 | 125 full-time | 2020-03-10 | $6,168.00 total lease cost |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |